IAS · As filed with the SEC

Integral Ad Science Holding income statement, by quarter

The statement as Integral Ad Science Holding presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED) · USD thousands, except per-share amounts

USD thousands, except per-share amountsQ3 2025
3 months ended Sep 30, 2025
Q2 2025
3 months ended Jun 30, 2025
Q1 2025
3 months ended Mar 31, 2025
Q4 2024†
3 months ended Dec 31, 2024
Revenue154,358149,204134,066153,038†
Operating expenses:
Cost of revenue (excluding depreciation and amortization shown below)———33,332†
Cost of revenue35,55334,34930,126—
Sales and marketing36,31735,79832,12830,753†
Technology and development22,63220,09919,70017,546†
General and administrative33,71526,54626,19624,310†
Depreciation and amortization17,90017,24216,46316,934†
Foreign exchange loss (gain), net667(5,782)(1,998)4,650†
Total operating expenses146,784128,252122,615127,525†
Operating income7,57420,95211,45125,513†
Interest income (expense), net595157(72)(571)†
Net income before income taxes8,16921,10911,37924,942†
Provision for income taxes(1,124)(4,701)(3,386)(9,671)†
Net income7,04516,4087,99315,271†
Net income per share - basic (in dollars per share)0.040.100.05—
Net income per share - diluted (in dollars per share)0.040.100.05—
Weighted average shares outstanding:
Basic (in shares)166,473,735165,018,978163,646,444—
Diluted (in shares)169,800,709167,347,688166,811,853—
Other comprehensive income:
Foreign currency translation adjustments943,3061,806(2,390)†
Total comprehensive income7,13919,7149,79912,881†

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.